News
SXTPW
0.0263
-24.64%
-0.0086
Weekly Report: what happened at SXTPW last week (1102-1106)?
Weekly Report · 2d ago
Weekly Report: what happened at SXTPW last week (1026-1030)?
Weekly Report · 11/02 09:35
60 Degrees Pharmaceutical Enters Sponsored Research Agreement With University Of Southern Mississippi To Assess The Potential Of Castanospermine In Nonclinical Models Of Alpha-Gal Syndrome
Benzinga · 10/28 12:32
Weekly Report: what happened at SXTPW last week (1019-1023)?
Weekly Report · 10/26 09:34
Weekly Report: what happened at SXTPW last week (1012-1016)?
Weekly Report · 10/19 09:34
Weekly Report: what happened at SXTPW last week (1005-1009)?
Weekly Report · 10/12 09:37
60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
Barchart · 10/06 07:10
Weekly Report: what happened at SXTPW last week (0928-1002)?
Weekly Report · 10/05 09:36
60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar
Barchart · 10/01 07:03
Weekly Report: what happened at SXTPW last week (0921-0925)?
Weekly Report · 09/28 09:34
Weekly Report: what happened at SXTPW last week (0914-0918)?
Weekly Report · 09/21 09:34
Weekly Report: what happened at SXTPW last week (0907-0911)?
Weekly Report · 09/14 09:36
Weekly Report: what happened at SXTPW last week (0831-0904)?
Weekly Report · 09/07 09:34
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference
Barchart · 09/03 07:04
Weekly Report: what happened at SXTPW last week (0824-0828)?
Weekly Report · 08/31 09:37
Weekly Report: what happened at SXTPW last week (0817-0821)?
Weekly Report · 08/24 09:37
Weekly Report: what happened at SXTPW last week (0810-0814)?
Weekly Report · 08/17 09:38
60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results
Barchart · 08/14 14:47
Weekly Report: what happened at SXTPW last week (0803-0807)?
Weekly Report · 08/10 09:35
Weekly Report: what happened at SXTPW last week (0727-0731)?
Weekly Report · 08/03 09:35
More
Webull provides a variety of real-time SXTPW stock news. You can receive the latest news about 60 Degrees Pharm through multiple platforms. This information may help you make smarter investment decisions.
About SXTPW
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.